LifeStance Health Group Announces Pricing of Secondary Public Offering
LifeStance Health priced a secondary offering of 22,250,000 shares at $12.35 per share, with all shares sold by existing stockholders rather than the company. LifeStance will receive no proceeds, but has agreed to repurchase 2,000,000 shares from the underwriter at the underwriter's cost — a repurchase conditioned on completion of the offering.
Key figures
- Offering Price
- 12.35
- Shares Offered
- 22250000
- Underwriter
- Barclays
- Expected close
- September 11, 2026
- Company receives proceeds
- No
- Company repurchase shares
- 2000000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.